162
Views
39
CrossRef citations to date
0
Altmetric
Review

Novel biomaterials for drug delivery

, &
Pages 639-656 | Published online: 26 May 2008

Bibliography

  • Vallet-Regí M. Ceramics for medical applications. Perspective Article. J Chem Soc Dalton Trans 2001;2:97-108
  • Vallet-Regí. Revisiting ceramics for medical applications. Perspective Article. Dalton Trans 2006;5211-20
  • Hulbert SF. An introduction to bioceramics. In: Hench LL, Wilson J, editors. Singapore: World Scientific; 1993
  • Wise DL, Trantolo DJ, Altobelli DE, et al. Encyclopedic handbook of biomaterials and bioengineering. New York: Marcel Dekker; 1995
  • Miller JA, Talton JD, Bathia S. Clinical performance of skeletal prosthesis. Hench LL, Wilson J, editors. London: Chapman and Hall; 1996
  • Abouaf M, Lilley E, Urffer D, et al. Hip joint prosthesis having a zirconia head and a ceramic cup. US0013625; 2002
  • Hench LL, Wilson J. Surface active biomaterials. Science 1984;226:630-6
  • Yamamuro T, Hench LL, Wilson J, editors. Calcium phosphate and hydroxyapatite ceramics. Handbook of bioactive ceramics, Volume 2. Boca Raton: CRC Press; 1990
  • Yamamuro T, Hench LL, Wilson J, editors. Bioactive glasses and glass ceramics. Handbook of bioactive ceramics, Volume 1. Boca Raton: CRC Press; 1990
  • Board of Regents, University of Florida. Bioglass coated A1203 ceramics. US4103002; 1977
  • University of Florida Research Foundation, Inc. Moldable bioactive compositions. US006051247; 2000
  • Turku Implant Team OY. Bioactive glass as a bone substitute. WO9317976; 1993
  • Hench LL, Polack JM. Third-generation biomedical materials. Science 2002;295:1014-7
  • Hing KA, Best SM, Bonfield W. Characterization of porous hydroxyapatite. J Mater Sci Mater Med 1999;10:135-45
  • del Real RP, Wolke JGC, Vallet-Regí M, Jansen J. New method to produce macropores in calcium phosphate cements. Biomaterials 2002;23:3673-80
  • Padilla S, Sánchez-Salcedo S, Vallet-Regí M. Bioactive glass as precursor of designed-architecture scaffolds for tissue engineering. J Biomed Mater Res A 2007;81A:224-32
  • Román J, Cabañas MV, Peña J, et al. An optimized beta-tricalcium phosphate and agarose scaffold fabrication technique. J Biomed Mater Res A 2008;84A:99-107
  • Calcitec, Inc. Forming porous calcium phosphate article used in making medical implant, involves immersing hardened calcium phosphate article in liquid(s), and subjecting immersed calcium phosphate article to heat treatment(s). US7083750; 2006
  • Pirhonen EM. Bone grafting materials. US2002016075; 2002
  • Tsuru K, Ohtsuki C, Osaka A, et al. Bioactivity of sol-gel derived organically modified silicates. 1. In vitro examination. Mater Sci Mater Med 1997;8:157-61
  • Chen Q, Miyaji F, Kokubo T, Nakamura T. Apatite formation on PDMS-modified CaO-SiO2-TiO2 hybrids prepared by sol-gel process. Biomaterials 1999;20:1127-32
  • Sanchez C, Julián B, Belleville P, Popall M. Applications of hybrid organic-inorganic nanocomposites. J Mater Chem 2005;15:3559-92
  • Vallet-Regí M, Arcos D. Nanostructured Hybrid materials for bone tissue regeneration. Curr Nanosci 2006;2:179-89
  • Colilla M, Salinas AJ, Vallet-Regí M. Amino-polysiloxane hybrid materials for bone reconstruction. Chem Mater 2006;18:5676-83
  • E.I.Dupong de Nemours & Co. Single component inorganic/organic network materials and precursors thereof. US005378790; 1995
  • Manzano M, Arcos D, Rodríguez-Delgado M, et al. Bioactive star gels. Chem Mater 2006;18:5696-703
  • Vallet-Regí M, Salinas AJ, Arcos D. From bioactive glasses to star gels. J Mater Sci Mater Mater Med 2006;17(11):1011-7
  • Bonfield W. Behiri JC, Charambilides B. Biomecanics: current interdisciplinary research. In: Perrin SM, Schneider E, editors. Dordrecht, The Netherlands: Martinus Nijhoff; 1984
  • Constantz BR, Ison IC, Fulmer MT, et al. Skeletal repair by in situ formation of the mineral phase of bone. Science 1995;267:1796-9
  • Hijón N, Manzano M, Salinas AJ, Vallet-Regí M. Bioactive CaO-SiO2-PDMS coatings on Ti6Al4V substrates. Chem Mater 2005;17:1591-6
  • Arcos D, Peña J, Vallet-Regí M. Influence of a SiO2-CaO-P2O5 sol-gel glass on the bioactivity and controlled release of ceramic/polymer/antibiotic mixed materials. Chem Mater 2003;15:4132-8
  • Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:234-48
  • Hing KA, Best SM, Bonfield W. Characterization of porous hydroxyapatite. J Mater Sci Mater Med 1999;10:135-45
  • Yanagisawa T, Shimizu T, Kuroda K, Kato C. The preparation of alkyltrimethylamonium–kanemite complexes and their conversion to microporous materials. Bull Chem Soc Jpn 1990;63:988-92
  • Kresge CT, Lonowicz ME, Roth WJ, et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992;359:710-2
  • Mobil Oil Corporation. Synthetic porous crystalline material its synthesis and use. WO9111390; 1991
  • Vallet-Regí, M, Rámila A, del Real RP, Pérez-Pariente. A new property of MCM-41: drug delivery system. J Chem Mater 2001;13:308-11
  • Muñoz B, Ramila A, Pérez-Pariente J, et al. MCM-41 organic modification as drug delivery rate regulator. Chem Mater 2003;15:500-3
  • Vallet-Regí M, Colilla M, Izquierdo-Barba I. Bioactive mesoporous silicas as controlled delivery systems: application in bone tissue regeneration. J Biomed Nanotechnol 2008;4:1-15
  • Izquierdo-Barba I, Ruiz-González L, Doadrio JC, et al. Tissue regeneration. A new property of mesoporous materials. Solid State Sci 2005;7:983-9
  • Vallet-Regí M, Izquierdo-Barba I, Rámila A, et al. Phosphorous doped MCM-41 as bioactive material. Solid State Sci 2005;7:233-7
  • Vallet-Regí M, Ruiz-González L, Izquierdo-Barba I, González-Calbet JM. Revisiting silica based ordered mesoporous materials: medical applications. J Mater Chem 2006;16:26-31
  • Yan XX, Yu CZ, Zhou XF, et al. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivity. Angew Chem Int Ed 2004;43:5980-4
  • López-Noriega A, Arcos D, Izquierdo-Barba, et al. Ordered mesoporous bioactive glasses for bone tissue regeneration. Chem Mater 2006;18:3137-44
  • Izquierdo-Barba I, Arcos D, Sakamoto Y, et al. High performance mesoporous bioceramics mimicking bone mineralization. Chem Mater doi: 10.1021/cm800172x
  • Hench LL, Splinter RJ, Greenlee TK, Allen WC. Bonding mechanism at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971;2:117-41
  • Hench LL. In: Ducheyne JP, Lemmons J, editors, Bioceramics: materials characteristics versus in vivo behavior, Volume 523. Annuals of the New York Academy of Sciences; 1988
  • Vallet-Regí M, Ragel CV, Salinas AJ. Glasses with medical applications. Eur J Inorg Chem 2003;1029-42
  • Kokubo T, Kushitani H, Sakka S, et al. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramics A-W. J Biomed Mater Res 1990;24:721-34
  • Li R, Clark AE, Hench LL. An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater 1991;2:231-9
  • Catauro M, Laudisio G, Costantini A, et al. Low temperature synthesis, structure and bioactivity of 2CaO.3SiO2. J Sol-Gel Sci Technol 1997;10:231-367
  • Vallet-Regí M, Arcos D, Pérez-Pariente J. Evolution of porosity during in vitro hydrocarbonate apatite in sol-gel glasses. J Biomed Mater Res 2000;51:23-8
  • Izquierdo-Barba I, Salinas AJ, Vallet-Regí M. In vitro calcium phosphate formation on sol-gel glasses of CaO-SiO2 system. J Biomed Mater Res 1999;47:243-50
  • Martínez A, Izquierdo-Barba I, Vallet-Regí M. Bioactivity of CaO-SiO2 binary glasses system. Chem Mater 2000;12:3080-8
  • Pereira MM, Clark AE, Hench LL. Effect of textural on rate of hydroxyapatite formation on gel silica surface. J Am Ceram Soc 1995;78:2463-8
  • The Trustees of the University of Pennsylvania. Incorporation of biologically active molecules into bioactive glasses. US005591453; 1997
  • Ragel CV, Vallet-Regí M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000;51:424-9
  • Radin S, Ducheyne P, Kamplain T, Tan BH. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization and in vitro release. J Biomed Mater Res 2001;57:313-20
  • Aughenbaugh W, Radin P, Ducheyne P. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameter on the in vitro release kinetics of vancomycin. J Biomed Mater Res 2001;57:321-6
  • Nicoll SB, Radin S, Santos EM, et al. In vitro release kinetics of biologically active transforming growth factor-β-1 from a novel porous glass carrier. Biomaterials 1997;18:853-9
  • Balas F, Arcos D. Pérez-Pariente, et al. Textural properties of SiO2-CaO-P2O5 glasses prepared by the sol-gel method. J Mater Res 2001;16:1345-48
  • Meseguer-Olmo L, Ros-Nicolas MJ, Clavel-Sainz M, et al. Biocompatibility and in vivo gentamicin release from bioactive sol-gel glass implants. J Biomed Mater Res 2002;61:458-65
  • Universidad Complutense de Madrid, Spain. Method for producing bioactive implants that are used as systems for the controlled release of antibiotics. WO02102430; 2002
  • Davis ME. Ordered mesoporous material for emerging applications. Nature 2002;417:813-21
  • Beck JS, Vartuli JC, Roth WJ, et al. A new family of mesoporous molecular–sieves prepared with liquid-crystal templates. J Am Chem Soc 1992;114:10834-43
  • Kruk M, Jaroniec M, Sakamoto Y, et al. Determination of pore size and pore wall structure of MCM-41 by using nitrogen adsorption, transmission electron microscopy, and X-ray diffraction. J Phys Chem B 2001;104:292-301
  • Kaneda M, Tsubakiyama T, Carlsson A, et al. Structural study of mesoporous MCM-48 and carbon networks synthesized in the spaces of MCM-48 by electron crystallography. J Phys Chem B 2002;106:1256-66
  • Impéror-Clerc M, Davidson P, Davidson A. Existence of a microporous corona around the mesopores of silica-based SBA-15 materials templated by triblock copolymers. J Am Chem Soc 2000;122:11925-33
  • Hartmann M, Vinu A. Mechanical stability and porosity analyses of large pore SBA-15 mesoporous molecular sieves by mercury porosimetry and organic adsorption. Langmuir 2002;18:8010-6
  • Che S, Lund K, Tatsumi T, et al. Direct observation of 3D mesoporous structure by Scanning Electron Microscopy (SEM): SBA-15 silica and CMK-5 carbon. Angew Chem Int Ed 2003;49:2182-5
  • Sakamoto Y, Kim TW, Ryoo R, Terasaki O. Three dimensional structure of large-pore mesoporous cubic Ia.-3d. silica with complementary pores and its carbon replica by electron crystallography. Angew Chem Int Ed 2004;43:5231-4
  • Horcajada P, Rámila A, Boulahya K, et al. Bioactivity in ordered mesoporous materials. Solid State Sci 2004;6:1295-300
  • Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 2006;12:5934-43
  • Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;47:7548-58
  • Ariga K, Vinu A, Hill JP, Mori T. Coordination chemistry and supramolecular chemistry in mesoporous nanospace. Coor Chem Rev 2007;251:2562-91
  • Salonen J, Kaukonen AM, Hirvonene J, Lehto V-P. Mesoporous silicon in drug delivery applications. J Pharm Sci 2008;97:632-53
  • Fan J, Yu C, Gao F, et al. Cubic mesoporous silica with large controllable entrance sizes and advanced adsorption properties. Angew Chem Int Ed 2003;42:3146-50
  • Horcajada P, Rámila A, Pérez-Pariente, Vallet-Regí M. Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor Mesopor Mater 2004;68:105-9
  • Higuchi T. Mechanism for sustained-action medication. J Pharm Sci 1963;52:1145-7
  • Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994;45:153-203
  • Peters T. All about albumin: biochemistry, genetics and medical applications. Academia Press, San Diego; 1995
  • Sugio S, Kashima A, Mochizuki S, et al. Crystal structure of human serum albumin at 2.5 angstrom resolution. Protein Eng 1999;12:439-46
  • Prouzet E, Pinnavaia TJ. Assembly of mesoporous molecular sieves containing wormhole motifs by a nonionic surfactant pathway: control of pore size by synthesis temperature. Angew Chem Int Ed 1997;55:559-60
  • Kruk M, Jaroniec M, Sayari A. New insights into pore-size expansion of mesoporous silicates using long-chain amines. Micropor Mesopor Mater 2000;35:545-53
  • Stucky GD, Chmelka BF, Zhao D, et al. Block polymer processing for mesostructured inorganic oxide materials. WO037705; 1999
  • Vallet-Regí M, Balas F, Colilla M, Manzano M. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog Solid State Chem 2007; published online 30 October 2007, doi:10.1016/j.progsolidstchem.2007.10.002
  • Kruk M, Jaroniec M, Sayari A. New approach to evaluate pore size distributions and surface areas for hydrophobic mesoporous solids. J Phys Chem B 1999;103:4590-8
  • El-Safty SA, Hanaoka T, Mizukami F. Design of highly stable, ordered cage mesostructured monoliths with controllable pore geometries and sizes. Chem Mater 2005;17:3137-45
  • Balas F, Manzano M, Horcajada P, Vallet-Regí M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 2006;128:8116-7
  • Crank J. The mathematics of diffusion. 2nd edition. Oxford University Press: Oxford; 1975
  • Costa P, Sousa-Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33
  • Buntkowsky G, Breitzke H, Adamczyk A, et al. Structural and dynamical properties of guest molecules confined in mesoporus silica materials revealed by NMR. Phys Chem Chem Phys 2007;9:4843-53
  • Charnay C, Begu S, Tourné-Péteilh L, et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm 2004;57:533-40
  • Azaïs T, Tourné-Péteilh C, Aussenac F, et al. Solid-state NMR study of ibuprofen confined in MCM-41. Chem Mater 2006;18:6382-90
  • Izquierdo-Barba I, Martínez A, Doadrio AL, et al. Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 2005;26:365-73
  • Exxonmobil Research and Engineering Company. Functionalized periodic mesoporous materials, their synthesis and use. US0072674; 2004
  • Hoffmann F, Cornelius M, Morell J, et al. Silica-based mesoporous organic-inorganic hybrid materials. Angew Chem Int Ed 2006;45:3216-51
  • Tourné-Péteilh C, Brunel D, Bégu S, et al. Synthesis and characterisation of ibuprofen-anchored MCM-41 silica and silica gel. New J Chem 2003:27:1415-8
  • Horcajada P, Rámila A, Férey G, Vallet-Regí M. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci 2006;8:1243-9
  • Balas F, Manzano M, Colilla M, Vallet-Regí M. L-Trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomater 2008;4(3):514-22
  • Doadrio JC, Sousa EMB, Izquierdo-Barba I, et al. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem 2006;16:462-7
  • Tang Q, Xu Y, Wu D, Sun Y. Hydrophobicity-controlled drug delivery system from organic modified mesoporous silica. Chem Lett 2006;35:474-5
  • Leonova E, Izquierdo-Barba I, Arcos D, et al. Multinuclear solid state NMR studies of ordered mesoporous bioactive glasses. J Phys Chem C 2008;112:5552-62.
  • Zhao L, Yan X, Zhou X, et al. Mesoporous bioactive glasses for controlled drug release. Micropor Mesopor Mater 2008;109:210-5
  • Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Rel 2006;110:522-30
  • Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-24
  • Yun H, Kim S, Hyeon Y. Design and preparation of bioactive glasses with hierarchical pore networks. Chem Commun 2007;2139-41
  • Cavallaro G, Pierro P, Palumbo FS, et al. Drug delivery devices based on mesoporous silicate. Drug Deliv 2004;11:41-6
  • Vallet-Regí M, Doadrio JC, Doadrio AL, et al. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics 2004;172:435-9
  • Doadrio AL, Sousa EMB, Doadrio JC, et al. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Rel 2004;97:125-32
  • Xue JM, Shi M. PLGA/mesoporous silica hybrid structure for controlled drug release. J Control Rel 2004;98:209-17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.